
NeuroPace Investor Relations Material
Latest events

Q4 2024
NeuroPace
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from NeuroPace Inc
Access all reports
NeuroPace, Inc. designs and develops devices to treat patients with refractory epilepsy. The company offers RNS System, a responsive neurostimulator device that is attached to the patient's skull, like a halo, and stimulated their brain with tiny electrical pulses. In addition, its product pipeline comprises RNS Stimulator to replace the traditional battery-powered pacemaker described above with a wireless charger; and rechargeable battery; wireless charger that eliminates the need to physically remove the device from the patient’s head in order to power up the battery; RNS Remote Monitor that enables patients to use an iPad application to indicate when they are having seizures or any other relevant symptoms; and RNS Access Manager that serves as an ingenious monitor for physicians and nurses treating patients. NeuroPace, Inc. was founded in 1997 and is headquartered in Mountain View, California.
Key slides for NeuroPace Inc


Q4 2024
NeuroPace Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
NeuroPace Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NPCE
Country
🇺🇸 United States